¼¼°èÀÇ ±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ½ÃÀå
Structural Biology and Molecular Modeling Techniques
»óǰÄÚµå : 1594978
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 84 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ½ÃÀåÀº 2030³â±îÁö 330¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 112¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ½ÃÀåÀº 2023-2030³â CAGR 16.7%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 330¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ SaaS & ½ºÅĵå¾ó·Ð ¸ðµ¨¸µ ÅøÀº CAGR 17.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 202¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µ¥ÀÌÅͺ£À̽º Åø ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 14.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 29¾ï ´Þ·¯, Áß±¹Àº CAGR 21.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ½ÃÀåÀº 2023³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 87¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³âÀÇ CAGRÀº 21.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 11.5%¿Í 14.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 12.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µ ±â¼úÀº ¾î¶»°Ô Drug Discovery¸¦ ÁøÇà½Ã۰í Àִ°¡?

±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µ ±â¼úÀº »ýüºÐÀÚÀÇ 3Â÷¿ø ±¸Á¶¸¦ ¿¬±¸ÇÏ°í ºÐÀÚ ¼öÁØ¿¡¼­ »ý¹°ÇÐÀû °úÁ¤À» ÀÌÇØÇϱâ À§ÇÑ »óÈ£ÀÛ¿ëÀ» ½Ã¹Ä·¹À̼ÇÇÏ´Â ±â¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ½Å¾à °³¹ß, ´Ü¹éÁú ¿£Áö´Ï¾î¸µ ¹× Áúº´ ¸ÞÄ¿´ÏÁòÀ» ÀÌÇØÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ´Ü¹éÁú, DNA ¹× ±âŸ »ýü ºÐÀÚÀÇ ±¸Á¶¿¡ ´ëÇÑ ÀλçÀÌÆ®À» Á¦°øÇÔÀ¸·Î½á ¿¬±¸ÀÚµéÀº ÀÌ·¯ÇÑ Á¢±Ù¹ýÀ» ÅëÇØ ½Å¾à Ÿ±êÀ» ½Äº°Çϰí, ½Å¾àÀ» ¼³°èÇϰí, »ýü ½Ã½ºÅÛ°úÀÇ »óÈ£ ÀÛ¿ëÀ» ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¦¾àȸ»çµéÀÌ ½Å¾à °³¹ßÀ» °¡¼ÓÈ­Çϰí Ç¥Àû Ä¡·áÁ¦¸¦ °³¹ßÇϰíÀÚ ÇÏ´Â °¡¿îµ¥, ±¸Á¶»ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µÀº Çö´ë »ý¸í°øÇÐ ¹× »ý¸í°úÇп¡¼­ ÇʼöÀûÀÎ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù.

±¸Á¶»ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

ÁÖ¿ä ±â¼ú·Î´Â X¼± °áÁ¤±¸Á¶ ºÐ¼®, ÇÙÀÚ±â°ø¸í(NMR) ºÐ±¤¹ý, ±ØÀú¿Â ÀüÀÚÇö¹Ì°æ(cryoEM), °è»ê ¸ðµ¨¸µ µîÀÌ ÀÖÀ¸¸ç, ±× Áß X¼± °áÁ¤±¸Á¶ ºÐ¼®Àº ´Ü¹éÁú ¹× ±âŸ »ýü ºÐÀÚÀÇ °íÇØ»óµµ ±¸Á¶¸¦ Á¦°øÇÒ ¼ö ÀÖÀ¸¸ç, °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¿ëµµ´Â ½Å¾à °³¹ß, ´Ü¹éÁú ¿£Áö´Ï¾î¸µ, À¯ÀüüÇÐ, Áúº´ ¿¬±¸¿¡ À̸£±â±îÁö ´Ù¾çÇϸç, ½Å¾à °³¹ßÀº È¿°úÀûÀÎ ¾à¹°À» ¼³°èÇϱâ À§ÇÑ Á¤¹ÐÇÑ ºÐÀÚ ÀλçÀÌÆ®ÀÇ Çʿ伺À¸·Î ÀÎÇØ Áß¿äÇÑ ºÎ¹®À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ¿¡´Â Á¦¾àȸ»ç, ¿¬±¸±â°ü, »ý¸í°øÇÐ ±â¾÷, Çмú±â°üÀÌ Æ÷ÇԵǸç, Á¦¾àȸ»ç´Â »õ·Î¿î Ä¡·áÁ¦¸¦ °³¹ßÇϱâ À§ÇØ ±¸Á¶»ý¹°Çп¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

±¸Á¶»ý¹°Çаú ºÐÀÚ ¸ðµ¨¸µÀº ÀǾàǰ °³¹ß¿¡¼­ ¾î¶»°Ô ÅëÇÕµÉ ¼ö Àִ°¡?

½Å¾à °³¹ß¿¡¼­ X¼± °áÁ¤ ±¸Á¶ ºÐ¼® ¹× Àú¿Â ÀüÀÚÇö¹Ì°æ°ú °°Àº ±¸Á¶»ý¹°ÇÐÀû ¹æ¹ýÀº ´Ü¹éÁú ±¸Á¶¸¦ ½Ã°¢È­Çϰí ÀáÀçÀûÀÎ ¾à¹° °áÇÕ ºÎÀ§¸¦ ½Äº°ÇÏ¿© ÇÕ¸®ÀûÀÎ ¾à¹° ¼³°è ¹× ±¸Á¶ ±â¹Ý ÃÖÀûÈ­¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. °è»ê ¸ðµ¨¸µÀº ¾à¹°°ú Ç¥ÀûÀÇ »óÈ£ÀÛ¿ëÀ» ¿¹ÃøÇÏ°í ´Ù¾çÇÑ ºÐÀÚ º¯ÇüÀÇ È¿°ú¸¦ ½Ã¹Ä·¹À̼ÇÇÏ¿© º¸´Ù °­·ÂÇÏ°í ¼±ÅÃÀûÀÎ ¾à¹°À» ¼³°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ´Ü¹éÁú ¿£Áö´Ï¾î¸µ¿¡¼­´Â ºÐÀÚ ¸ðµ¨¸µÀ» ÅëÇØ È¿¼Ò³ª ´Ü¹éÁúÀ» º¯Çü½ÃÄÑ ¾ÈÁ¤¼º°ú Ȱ¼º, ƯÀ̼ºÀ» ³ô¿© »õ·Î¿î ¹ÙÀÌ¿ÀÀǾàǰÀ̳ª »ê¾÷¿ë È¿¼Ò¸¦ ¸¸µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯Àüü ¿¬±¸¿Í Áúº´ ¿¬±¸´Â ´Ü¹éÁúÀÇ ±¸Á¶¸¦ º¯È­½ÃŰ´Â À¯ÀüÀÚ º¯À̸¦ ½Äº°ÇÔÀ¸·Î½á ±¸Á¶»ý¹°ÇÐÀÇ µµ¿òÀ» ¹Þ¾Æ ¸ÂÃãÇü Ä¡·á¹ýÀ» °³¹ßÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

±¸Á¶»ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

±¸Á¶»ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ½ÃÀåÀÇ ¼ºÀåÀº ¼¼ºÎÀûÀÎ ºÐÀÚÀû ÀλçÀÌÆ®À» ÇÊ¿ä·Î Çϴ ǥÀû ¾à¹° °³¹ß ¹× Á¤¹Ð ÀÇÇп¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±ØÀú¿Â ÀüÀÚÇö¹Ì°æ°ú °°Àº À̹Ì¡ ±â¼ú, ´õ ºü¸¥ ÄÄÇ»ÆÃ ¼º´É, ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ¹ßÀüÀ¸·Î ±¸Á¶ ºÐ¼® ¹× ¸ðµ¨¸µÀÇ ÇØ»óµµ, Á¤È®µµ, ¼Óµµ°¡ Çâ»óµÇ¾î ÀǾàǰ °³¹ß ¹× Áúº´ ¿¬±¸¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ¾Ï, ½Å°æ ÅðÇ༺ Áúȯ, °¨¿°¼º Áúȯ°ú °°Àº º¹ÀâÇÑ Áúº´¿¡ ´ëÇÑ Ä¡·á¹ý °³¹ß¿¡ ÁßÁ¡À» µÎ¸é¼­ ¿¬±¸ÀÚµéÀÌ Áúº´ÀÇ ¸ÞÄ¿´ÏÁòÀ» ÀÌÇØÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀ» ¼³°èÇÏ·Á´Â ¿òÁ÷ÀÓÀÌ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ý¸í°øÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ¿¬±¸ Çù·Â È®´ë, »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀçÁ¤ Áö¿øÀº ½Å¾à °³¹ß ¹× »ý¹°ÀÇÇÐ ¿¬±¸¿¡¼­ ±¸Á¶»ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µÀÇ È°¿ëÀ» ÃËÁøÇÏ¿© ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Åø(SaaS &½ºÅĵå¾ó·Ð ¸ðµ¨¸µ, µ¥ÀÌÅͺ£À̽º, °¡½ÃÈ­&ÇØ¼®, ±âŸ Åø)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 23»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Structural Biology and Molecular Modeling Techniques Market to Reach US$33.0 Billion by 2030

The global market for Structural Biology and Molecular Modeling Techniques estimated at US$11.2 Billion in the year 2023, is expected to reach US$33.0 Billion by 2030, growing at a CAGR of 16.7% over the analysis period 2023-2030. SaaS & Standalone Modeling Tool, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$20.2 Billion by the end of the analysis period. Growth in the Databases Tool segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 21.6% CAGR

The Structural Biology and Molecular Modeling Techniques market in the U.S. is estimated at US$2.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$8.7 Billion by the year 2030 trailing a CAGR of 21.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Structural Biology and Molecular Modeling Techniques Market - Key Trends and Drivers Summarized

How Are Structural Biology and Molecular Modeling Techniques Advancing Drug Discovery?

Structural biology and molecular modeling techniques involve studying the three-dimensional structures of biomolecules and simulating their interactions to understand biological processes at the molecular level. These techniques are crucial in drug discovery, protein engineering, and understanding disease mechanisms. By providing insights into the structures of proteins, DNA, and other biomolecules, these approaches allow researchers to identify drug targets, design new drugs, and predict their interactions with biological systems. As pharmaceutical companies aim to accelerate drug development and create targeted therapies, structural biology and molecular modeling have become indispensable tools in modern biotechnology and life sciences.

What Are the Key Segments in the Structural Biology and Molecular Modeling Market?

Key technologies include X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, cryo-electron microscopy (cryo-EM), and computational modeling, with X-ray crystallography holding the largest market share due to its ability to provide high-resolution structures of proteins and other biomolecules. Applications cover drug discovery, protein engineering, genomics, and disease research, with drug discovery representing a significant segment driven by the need for precise molecular insights to design effective drugs. End-users include pharmaceutical companies, research institutes, biotechnology firms, and academic institutions, with pharmaceutical companies leading the market as they invest heavily in structural biology to develop novel therapeutics.

How Are Structural Biology and Molecular Modeling Integrated Across Drug Development?

In drug discovery, structural biology techniques like X-ray crystallography and cryo-EM help visualize the structures of proteins and identify binding sites for potential drugs, enabling rational drug design and structure-based optimization. Computational modeling predicts the interactions between drugs and their targets, simulating the effects of different molecular modifications, which supports the design of more potent and selective drugs. In protein engineering, molecular modeling aids in modifying enzymes and proteins to enhance their stability, activity, or specificity, leading to new biopharmaceuticals and industrial enzymes. Additionally, genomics and disease research benefit from structural biology by identifying genetic mutations that alter protein structures, aiding in the development of personalized therapies.

What Factors Are Driving the Growth in the Structural Biology and Molecular Modeling Market?

The growth in the Structural Biology and Molecular Modeling market is driven by several factors, including increasing demand for targeted drug discovery and precision medicine that require detailed molecular insights. Advancements in imaging techniques like cryo-EM, faster computing power, and machine learning algorithms have improved the resolution, accuracy, and speed of structural analysis and modeling, supporting broader applications in drug development and disease research. The focus on developing treatments for complex diseases like cancer, neurodegenerative disorders, and infectious diseases has further fueled demand, as researchers seek to understand disease mechanisms and design effective therapies. Additionally, rising investments in biotechnology, expanded research collaborations, and government funding for life sciences research have contributed to market growth, encouraging the use of structural biology and molecular modeling in drug discovery and biomedical research.

SCOPE OF STUDY:

The report analyzes the Structural Biology and Molecular Modeling Techniques market in terms of US$ Million by the following Tool, and Geographic Regions/Countries:

Segments:

Tool (SaaS & Standalone Modeling, Databases, Visualization & Analysis, Other Tools)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 23 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â